The 2022 AHA/ACC/HFSA Heart Failure Guideline emphasizes primary and secondary prevention to address the rising health and economic burden of heart failure in the United States.
This review underscores the 2022 AHA/ACC/HFSA guidelines' shift in focus toward primary and secondary prevention to mitigate the growing prevalence of heart failure.
The prevalence of heart failure (HF) in the United States (U.S.) is estimated at over 6 million adults, with the incidence continuing to increase. A large proportion of the U.S. population is also at risk of HF due to the high prevalence of established HF risk factors, such as hypertension, diabetes, and obesity. Many individuals have multiple risk factors, placing them at even higher risk. In addition, these risk factors disproportionately impact various racial and ethnic groups. Recognizing the rising health and economic burden of HF in the U.S., the 2022 American Heart Association / American College of Cardiology / Heart Failure Society of America (AHA/ACC/HFSA) Heart Failure Guideline placed a strong emphasis on prevention of HF. The purpose of this review is to highlight the role of both primary and secondary prevention in HF, as outlined by the recent guideline, and address the role of the preventive cardiology community in reducing the prevalence of HF in at-risk individuals.
Abovich et al. (Sun,) conducted a review in Heart failure. AHA/ACC/HFSA 2022 Heart Failure Guidelines was evaluated. The 2022 AHA/ACC/HFSA Heart Failure Guideline emphasizes primary and secondary prevention to address the rising health and economic burden of heart failure in the United States.